ACRV vs BR · $65.1M cap vs P/E 16, rev $7.48B
Acrivon Therapeutics, Inc. Common Stock (ACRV) versus Broadridge Financial Solutions Inc (BR) — a side-by-side from cached financials, not a winner call.
Acrivon Therapeutics, Inc. Common Stock (ACRV) is a biotechnology company listed on NASDAQ.
Broadridge Financial Solutions Inc (BR) is a information technology services company listed on US.
ACRV does not have a complete income-statement cache yet.
Latest reported BR revenue for 2026-06-30 was $7.48B. Net income was $1.12B. Revenue was up 8.5% from 2025-06-30 to 2026-06-30. BR currently screens at market cap $17.65B and trailing P/E 16.3.
ACRV currently screens at market cap $65.1M. BR currently screens at market cap $17.65B and trailing P/E 16.3.
Not investment advice. Open the ACRV and BR stock pages for the full models.
Not investment advice.